Evidence map›Paper›PMID 33201360›Full record

Observational studyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19.

Imen Kacem, Alya Gharbi, Chahida Harizi, Emira Souissi, Mouna Safer, Amina Nasri, Hajer Letaief, Manel Akkari, Aicha Hechaichi, Saloua Mrabet and 7 more

Abstract readObservational Study
In one paragraph

Observational study in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Neurological and neuropsychiatric manifestations in hospitalised patients with COVID-19.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Neurological update: COVID-19.Journal of neurology · 2021
    Review
  15. Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.medRxiv : the preprint server for health sciences · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Neurological sequelae of COVID-19: a review.The Egyptian journal of neurology, psychiatry and neurosurgery · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Imen KacemDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Alya GharbiDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Chahida HariziFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Emira SouissiDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Mouna SaferFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Amina NasriDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Hajer LetaiefFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Manel AkkariDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Aicha HechaichiFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Saloua MrabetDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Sonia DhaouadiFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Mouna Ben DjebaraDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Sondes DerouicheFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Amina GargouriDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia.
Mohamed ChahedFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Nissaf Ben AlayaFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Riadh GouiderDepartment of Neurology, LR18SP03, Clinical Investigation Center of Neurosciences and Mental Health, Universitary Hospital Razi-Mannouba, Tunis, Tunisia. riadh.gouider@gnet.tn.ORCID https://orcid.org/0000-0001-9615-3797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA wide range of neurological manifestations has been described in COVID-19.

methodsIn this nationwide retrospective observational study, patients in Tunisia diagnosed with COVID-19 between the 2nd of March and the 16th of May 2020 were contacted by telephone. We collected demographic and clinical data and specified characteristics and evolution of main neurological symptoms.

resultsOf 1034 confirmed COVID-19 patients, 646 were included (mean age 42.17 years old) and 466 (72.1%) had neurological symptoms. Neurological symptoms were isolated 22.7% (n = 106). Headache was the most frequent neurological symptom (n = 279, 41.1%): mainly frontotemporal (n = 143, 51.1%) and mild or moderate (n = 165, 59.1%). When associated with fever (n = 143, 51.3%), headache was more likely to be severe and present at onset. Recovery was reported in 83.2%. Smell and taste impairment were found in 37.9% (n = 245) and 36.8% (n = 238) respectively. Among them, 65.3% (156/239) were anosmic and 63.2% (146/231) were ageusic. A complete improvement was found in 72.1% (174/240) of smell impairment and in 76.8% (179/233) of taste impairment. Myalgia (n = 241, 37.3%) and sleep disturbances (n = 241, 37.3%) were also frequent. Imported cases had more neurological symptoms (p = 0.001). In 14.5%, neurological symptoms preceded the respiratory signs (RS). RS were associated with more frequent (p = 0.006) and numerous (p < 0.001) neurological symptoms.

conclusionsNeurological symptoms in COVID-19 are frequent, can be isolated and present at onset. A total recovery is the most recorded outcome. RS are predictive of neurological symptoms. Studies in to virus and host genetics should be considered to understand the different phenotypes.

Indexed as

AdultAgedAgeusiaCOVID-19FemaleHeadacheHumansMaleMiddle AgedMyalgiaOlfaction DisordersRetrospective StudiesSleep Wake DisordersTunisiaYoung AdultCOVID-19NeurologicalSARS-CoV-2Symptoms/manifestationsTunisia

Identifiers

PMID33201360
PMCPMC7670015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.